Cargando…
Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method
BACKGROUND: Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid synthesis that can cause progressive neurological damage and premature death. Detection of CTX in the newborn period would be beneficial since an effective treatment is available. We previously described a liqui...
Autores principales: | Bleyle, Lisa, Huidekoper, Hidde H., Vaz, Frederic M., Singh, Renu, Steiner, Robert D., DeBarber, Andrea E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908045/ https://www.ncbi.nlm.nih.gov/pubmed/27331003 http://dx.doi.org/10.1016/j.ymgmr.2016.02.002 |
Ejemplares similares
-
Toward Newborn Screening of Cerebrotendinous Xanthomatosis: Results of a Biomarker Research Study Using 32,000 Newborn Dried Blood Spots
por: Hong, Xinying, et al.
Publicado: (2020) -
Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings
por: Guenzel, Adam J., et al.
Publicado: (2021) -
Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
por: Huidekoper, Hidde H., et al.
Publicado: (2015) -
Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newborns
por: Vaz, Frédéric M., et al.
Publicado: (2023) -
Cerebrotendinous xanthomatosis
por: Vadapalli, Satyadev
Publicado: (2013)